Raymond James Financial Inc Royalty Pharma PLC Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Raymond James Financial Inc holds 1,086,989 shares of RPRX stock, worth $35.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,086,989
Previous 783,633
38.71%
Holding current value
$35.5 Million
Previous $20 Million
69.27%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
483Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.34 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$752 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$438 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$398 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.3B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...